• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真性局部皮肤复发性恶性黑色素瘤的预后与治疗

The prognosis and treatment of true local cutaneous recurrent malignant melanoma.

作者信息

Brown C D, Zitelli J A

出版信息

Dermatol Surg. 1995 Apr;21(4):285-90. doi: 10.1111/j.1524-4725.1995.tb00174.x.

DOI:10.1111/j.1524-4725.1995.tb00174.x
PMID:7728476
Abstract

BACKGROUND

The prognosis and treatment of true local cutaneous recurrent malignant melanoma is presently unknown. We define this entity as melanoma bearing an in situ component that recurs contiguous with the scar of the primary excision. Although previously uncommon, the incidence of true local recurrent melanoma may rise due to the recent use of more narrow margins for excision of thin primary melanoma.

OBJECTIVE

We hypothesized that there is a difference in prognosis between true local cutaneous recurrent melanoma versus local recurrence from satellite or in-transit metastases. Also, we defined guidelines for the surgical management of true local cutaneous recurrent melanoma.

METHODS

We calculated the surgical margin necessary to reach a tumor-free plane using Mohs surgery in 50 patients with true local recurrent melanoma. Patient survival was determined by the Kaplan-Meier method.

RESULTS

Seventy-six percent of the tumors were completely excised using a margin of less than 1 cm. However, a margin of up to 2 cm was required to successfully treat all 50 patients. Thicker tumors did require significantly larger margins. The Kaplan-Meier 5-year overall and melanoma survival rates were 89% and 98%, respectively. The 5-year disease-free survival rate was 66%.

CONCLUSION

The prognosis of true local recurrent melanoma is related to tumor thickness. We recommend full-thickness excision of the entire old scar including a 2-cm margin or Mohs surgery if a narrower margin of resection is desired.

摘要

背景

目前,真正的局部皮肤复发性恶性黑色素瘤的预后和治疗方法尚不清楚。我们将这一实体定义为具有原位成分的黑色素瘤,其复发部位与原发灶切除瘢痕相邻。虽然以前并不常见,但由于最近对薄型原发性黑色素瘤采用了更窄的切除边缘,真正的局部复发性黑色素瘤的发病率可能会上升。

目的

我们假设真正的局部皮肤复发性黑色素瘤与卫星灶或移行转移导致的局部复发在预后上存在差异。此外,我们还制定了真正的局部皮肤复发性黑色素瘤的手术治疗指南。

方法

我们对50例真正的局部复发性黑色素瘤患者采用莫氏手术计算达到无瘤平面所需的手术切缘。采用Kaplan-Meier法确定患者生存率。

结果

76%的肿瘤在切缘小于1 cm的情况下被完全切除。然而,要成功治疗所有50例患者,需要高达2 cm的切缘。较厚的肿瘤确实需要明显更大的切缘。Kaplan-Meier法计算的5年总生存率和黑色素瘤生存率分别为89%和98%。5年无病生存率为66%。

结论

真正的局部复发性黑色素瘤的预后与肿瘤厚度有关。如果希望采用更窄的切除边缘,我们建议完整切除整个旧瘢痕,包括2 cm的切缘,或采用莫氏手术。

相似文献

1
The prognosis and treatment of true local cutaneous recurrent malignant melanoma.真性局部皮肤复发性恶性黑色素瘤的预后与治疗
Dermatol Surg. 1995 Apr;21(4):285-90. doi: 10.1111/j.1524-4725.1995.tb00174.x.
2
Surgical margins for excision of primary cutaneous melanoma.原发性皮肤黑色素瘤切除的手术切缘
J Am Acad Dermatol. 1997 Sep;37(3 Pt 1):422-9. doi: 10.1016/s0190-9622(97)70144-0.
3
Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.Mohs 显微描记手术治疗躯干和四肢近端侵袭性黑色素瘤的长期疗效。
J Am Acad Dermatol. 2021 Mar;84(3):661-668. doi: 10.1016/j.jaad.2020.07.113. Epub 2020 Aug 4.
4
Mohs micrographic surgery for the treatment of primary cutaneous melanoma.莫氏显微外科手术治疗原发性皮肤黑色素瘤。
J Am Acad Dermatol. 1997 Aug;37(2 Pt 1):236-45. doi: 10.1016/s0190-9622(97)80131-4.
5
Cutaneous head and neck melanoma treated with Mohs micrographic surgery.采用莫氏显微外科手术治疗的头颈部皮肤黑色素瘤。
J Am Acad Dermatol. 2005 Jan;52(1):92-100. doi: 10.1016/j.jaad.2004.08.038.
6
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.2cm 与 4cm 手术切缘用于厚度大于 2mm 的原发性皮肤黑色素瘤:一项随机、多中心试验。
Lancet. 2011 Nov 5;378(9803):1635-42. doi: 10.1016/S0140-6736(11)61546-8. Epub 2011 Oct 23.
7
Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.原发性皮肤黑色素瘤的最佳切缘:一项系统评价和荟萃分析。
Can J Surg. 2003 Dec;46(6):419-26.
8
Wide excision without radiation for desmoplastic melanoma.促纤维增生性黑色素瘤的广泛切除且不进行放疗
Cancer. 2005 Oct 1;104(7):1462-7. doi: 10.1002/cncr.21311.
9
A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.对于厚度大于 2 毫米的皮肤恶性黑色素瘤,1 厘米与 2 厘米切除边缘的回顾性研究。
J Am Acad Dermatol. 2015 Jun;72(6):1054-9. doi: 10.1016/j.jaad.2015.03.029. Epub 2015 Apr 13.
10
Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas < or =2 mm thick.组织病理学切除切缘影响局部复发率:对2681例厚度≤2mm的黑色素瘤患者的分析
Ann Surg. 2005 Feb;241(2):326-33. doi: 10.1097/01.sla.0000152014.89434.96.

引用本文的文献

1
The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial.黑色素瘤幸存者复发性和第二原发性黑色素瘤检测的自我导向综合癌症后续护理干预措施:试点随机对照试验。
JMIR Cancer. 2022 Sep 8;8(3):e37539. doi: 10.2196/37539.
2
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death.基于原发性黑色素瘤肿瘤标准苏木精-伊红(H&E)图像的深度学习可识别有内脏复发和死亡风险的患者。
Clin Cancer Res. 2020 Mar 1;26(5):1126-1134. doi: 10.1158/1078-0432.CCR-19-1495. Epub 2019 Oct 21.
3
Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.
实现黑色素瘤自我导向综合癌症康复(ASICA):一项随机患者为中心的先导试验方案,旨在将 ASICA 干预作为早期检测复发性和第二原发黑色素瘤的手段。
Trials. 2019 Jun 3;20(1):318. doi: 10.1186/s13063-019-3453-x.
4
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.验证黑色素瘤免疫特征(MIP),一种用于 II-III 期黑色素瘤的预后免疫基因预测评分。
Clin Cancer Res. 2019 Apr 15;25(8):2494-2502. doi: 10.1158/1078-0432.CCR-18-2847. Epub 2019 Jan 15.
5
[Recurrence of malignant achromic melanoma of the nail: report of a case].[甲部恶性无色素性黑素瘤复发:1例报告]
Pan Afr Med J. 2015 Dec 2;22:320. doi: 10.11604/pamj.2015.22.320.8319. eCollection 2015.
6
[Malignant head and neck melanoma: Part 2: Therapy].[恶性头颈部黑色素瘤:第二部分:治疗]
HNO. 2015 Aug;63(8):593-602; quiz 603-4. doi: 10.1007/s00106-015-0034-5.
7
Diagnosis and management of lentigo maligna: a review.恶性雀斑样痣的诊断与管理:综述
Drugs Context. 2015 May 29;4:212281. doi: 10.7573/dic.212281. eCollection 2015.
8
The changing prognosis of melanoma.黑色素瘤不断变化的预后。
Curr Oncol Rep. 2000 Jul;2(4):322-8. doi: 10.1007/s11912-000-0025-9.